Update on GALLANT: A Phase 2 Study Using Metronomic Gemcitabine, Doxorubicin, and Docetaxel Plus Nivolumab in Previously Treated Sarcoma (NCT04535713).
Journal of Clinical Oncology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined